Aurinia Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:AUPH) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 550.64 M504.85 M502.56 M527.53 M751.59 M Total liabilities 173.17 M154.66 M167.26 M161.76 M170.26 M Total equity 377.48 M350.19 M335.3 M365.77 M581.33 M Total liabilities & shareholders' equities 550.64 M504.85 M502.56 M527.53 M751.59 M Total debt ————— Net debt —————

Haberler

SOLV Energy Stock, Applied Blockchain And WisdomTree Join A Dozen Other New Stocks On IBD Watchlists

Cipher Mining Stock, Five Below, Indivior Among 10 New Stocks On IBD Watchlists

Gold Stocks, AI Leader Broadcom Among 25 Newcomers To Best Stock Lists

Google Parent Alphabet Leads 14 Outstanding Names Onto These Best Stock Lists

Kezar Life Sciences birleşme sonrası kira iptalini ve yönetici ayrılıklarını açıkladı

Aris Mining Stock, Franco-Nevada, HSBC Among 30 New Stocks On IBD Watchlists

Jefferies, satın alma sonrası Kezar Life Sciences hisse notunu korudu

Kezar Life Sciences hisseleri Aurinia satın alma anlaşmasıyla sıçradı

Aurinia Pharmaceuticals: New Management, Continued Lupkynis Performance (NASDAQ:AUPH)

Chip Gear Maker ASML Shoots Higher, Leads 16 New To IBD 50, Other Best Stock Lists

Curtiss-Wright, Other Top Aerospace Plays Among 24 New To Best Stock Lists

Mutiny At Aurinia Pharmaceuticals? Biotech Soars On C-Suite Shake-Up